“The present situation has uncovered some structural weaknesses from the EU’s medicines supply chain along with a significant dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides said. She advisable that offer chain troubles be tackled in an EU pharmaceutical system envisioned to generally be launch